Novartis Confirms Spin-off of Sandoz on October 4, 2023

Novartis has confirmed that it will spin off its Sandoz generics division on October 4, 2023. The spin-off will create two independent companies: Novartis, which will focus on innovative medicines, and Sandoz, which will focus on generics and biosimilars.

The spin-off is part of Novartis’s strategy to focus on its core businesses and to create two more agile and competitive companies. Novartis has said it expects the spin-off to be completed in the first half 2023.

The spin-off of Sandoz will be a major event in the pharmaceutical industry. Sandoz is one of the world’s largest generics companies, and Novartis is one of the world’s largest pharmaceutical companies. The spin-off will create two new independent companies with strong positions in their respective markets.

Novartis has said it expects the spin-off to create value for shareholders and patients. Novartis shareholders will receive one share of Sandoz for every five shares of Novartis that they own. Sandoz will be listed on the SIX Swiss Exchange, with an American Depositary Receipt (ADR) program in the US.

The spin-off of Sandoz is a significant development for the global healthcare industry. It is a sign that Novartis is committed to its core businesses and creating a more competitive and innovative pharmaceutical industry.

The spin-off of Sandoz is also a positive development for patients. It is likely to lead to increased competition in the generics market, which could lead to lower prices for patients.

It will be interesting to see how the two new companies, Novartis and Sandoz, perform in the future. The spin-off may be a success for both companies and patients.

Editor's Choice

Posts You Might Like

A Leader in Unrivalled Security | Joseph McGee

Following a distinguished Law Enforcement career Joe McGee founded The Securitatem Group to provide contemporary global operational specialist security and specialist security training products and services for private clients, corporate organisations, and Government bodies. They deliver a wide range of services, including complete end-to-end protection packages, close protection, residential security, protection drivers, and online and physical installations. They provide covert and overt investigations and specialist surveillance services with a Broad range of weapons and tactical-based training, including conflict management, risk and threat management, tactical training, tactical medicine, and command and control training.

Styling the Perfect Wine | Jay Wright

Jay Wright, CEO and Co-Owner of Virgin Wines infectious energy, enthusiasm, passion and drive has been instrumental in creating an environment that encourages talent to thrive and a culture that puts the customer at the very heart of every decision-making process.

Leading Farmacosmo with Vision and Innovation | Fabio de Concilio

Fabio de Concilio is the visionary CEO & Chairman of the Board at Farmacosmo, a leading organization dedicated to mental health and community support services. With a deep commitment to identifying and meeting customer needs, Fabio ensures that high standards are maintained across the board.

Creating A Cleaner & Healthier Environment | David CM Carter

Character Determines Destiny – so said Aristotle. And David CM Carter believes that more than anything else. For David, it has been numerous years of research into codifying Entelechy Academy’s 54 character qualities that underpin everything he stands for as a leader and teacher.

The-corporate-magazine-15

Leave us a message

Subscribe

Fill the form our team will contact you

Advertise with us

Fill the form our team will contact you​